Revenue
2022
2023
2024
2025
Surgical Innovations Group plc (SUN)
Price£0.00425Cached quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | £11.6M | £11.9M | £12.0M | £11.3M | — |
| Research & development | £1.3M | £1.1M | £1.1M | £1.2M | — |
| Operating expenses | £3.9M | £4.1M | £4.0M | £3.8M | — |
| Operating income | −£878,000 | −£638,000 | −£588,000 | £73,000 | — |
| Operating margin | −7.57% | −5.34% | −4.89% | 0.64% | — |
| EBITDA | −£220,000 | −£99,000 | £161,000 | £628,000 | — |
| EBITDA margin | −1.90% | −0.83% | 1.34% | 5.54% | — |
| Net income | −£895,000 | −£1.9M | −£509,000 | £264,000 | — |
| Net profit margin | −7.71% | −16.27% | −4.24% | 2.33% | — |
| Basic EPSper basic share | -£0.00 | — | -£0.00 | £0.00 | -£0.00 |
| Diluted EPSper diluted share | -£0.00 | — | -£0.00 | £0.00 | -£0.00 |